$172.32
3M Ago | 1M Ago | Current | |
Buy | 6 | 6 | 5 |
Outperform | 7 | 7 | 8 |
Hold | 3 | 3 | 2 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
The latest share price target for Reata Pharmaceuticals Inc (RETA) is $172.45, offered by 15 analysts offering 12-month price forecasts.
Reata Pharmaceuticals Inc (RETA) has a maximum of 0 downside potential, based on 15 analysts offering 12-month price forecasts.
Based on 15 analysts tracking and researching Reata Pharmaceuticals Inc (RETA), 86.67% have a buy recommendation. Remaining 13.33% have either sell or hold recommendations.
The latest share price of Reata Pharmaceuticals Inc (RETA) is $172.32 as of 24/09/2023.
13 of total 15 analysts offering stock ratings for Reata Pharmaceuticals Inc RETA have recommended buy rating.